Madhukar H. Trivedi, MD

Exercise vs Health Education for Treating Stimulant Use Disorder

February 14, 2017

Early evidence suggests that exercise may be an effective treatment approach for stimulant use disorders. Here, find out if exercise was superior to a health education intervention in reducing...

Madhukar H. Trivedi , Tracy L. Greer , Chad D. Rethorst , et al

Original Research

Postexercise Affect as Predictor of Response in Depression

August 24, 2016

How can you make the process of choosing the right antidepressant therapy more strategic and less trial and error? Identification of behavioral and biological markers will lead to early...

Anisha M. Suterwala , Chad D. Rethorst , Thomas J. Carmody , et al

Article

Prevalence and Impact of Obsessive-Compulsive Symptoms in Depression: A STAR*D Report

December 23, 2015

Lee Baer , Madhukar H. Trivedi , Ilana Huz , et al

Original Research

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Vortioxetine 10 mg and 20 mg in Adults With Major Depressive Disorder

May 27, 2015

Paula L. Jacobsen , Atul R. Mahableshwarkar , Michael Serenko , et al

Original Research

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Vortioxetine in Adults With Major Depressive Disorder

May 27, 2015

Atul R. Mahableshwarkar , Paula L. Jacobsen , Michael Serenko , et al

Original Research

Inflammation, Obesity, and Metabolic Syndrome in Depression: Analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES)

December 24, 2014

Chad D. Rethorst , Ira Bernstein , Madhukar H. Trivedi

Commentary

Using Measurement-Based Care With Patient Involvement to Improve Outcomes in Depression

November 28, 2013

Larry Culpepper , Madhukar H. Trivedi

Original Research

Influence of Sex and Menopausal Status on Response, Remission, and Recurrence in Patients With Recurrent Major Depressive Disorder Treated With Venlafaxine Extended Release or Fluoxetine: Analysis of Data From the PREVENT Study

November 26, 2013

Susan G. Kornstein , Ronald D. Pedersen , Peter J. Holland , et al

Original Research

A Randomized Controlled Trial of the Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults With Residual Symptoms of Major Depressive Disorder After Treatment With Escitalopram

August 15, 2013

Madhukar H. Trivedi , Andrew J. Cutler , Cynthia Richards , et al

Educational Activity

Evaluating and Monitoring Treatment Response in Depression Using Measurement-Based Assessment and Rating Scales

July 15, 2013

Madhukar H. Trivedi

Original Research

Quantitative Electroencephalogram Biomarkers for Predicting Likelihood and Speed of Achieving Sustained Remission in Major Depression: A Report From the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) Trial

January 15, 2013

Ian A. Cook , Aimee M. Hunter , William S. Gilmer , et al

Original Research

The Impact of Chronic Depression on Acute and Long-Term Outcomes in a Randomized Trial Comparing Selective Serotonin Reuptake Inhibitor Monotherapy Versus Each of 2 Different Antidepressant Medication Combinations

May 29, 2012

Sharon C. Sung , Charlotte L. Haley , Stephen R. Wisniewski , et al

Exercise vs Health Education for Treating Stimulant Use Disorder

Postexercise Affect as Predictor of Response in Depression

Prevalence and Impact of Obsessive-Compulsive Symptoms in Depression: A STAR*D Report

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Vortioxetine 10 mg and 20 mg in Adults With Major Depressive Disorder

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Vortioxetine in Adults With Major Depressive Disorder

Inflammation, Obesity, and Metabolic Syndrome in Depression: Analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES)

Using Measurement-Based Care With Patient Involvement to Improve Outcomes in Depression

Influence of Sex and Menopausal Status on Response, Remission, and Recurrence in Patients With Recurrent Major Depressive Disorder Treated With Venlafaxine Extended Release or Fluoxetine: Analysis of Data From the PREVENT Study

A Randomized Controlled Trial of the Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults With Residual Symptoms of Major Depressive Disorder After Treatment With Escitalopram

Evaluating and Monitoring Treatment Response in Depression Using Measurement-Based Assessment and Rating Scales

Quantitative Electroencephalogram Biomarkers for Predicting Likelihood and Speed of Achieving Sustained Remission in Major Depression: A Report From the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) Trial

The Impact of Chronic Depression on Acute and Long-Term Outcomes in a Randomized Trial Comparing Selective Serotonin Reuptake Inhibitor Monotherapy Versus Each of 2 Different Antidepressant Medication Combinations

ELSEWHERE:

FOLLOW US:

Madhukar H. Trivedi, MD

Exercise vs Health Education for Treating Stimulant Use Disorder

Postexercise Affect as Predictor of Response in Depression

Prevalence and Impact of Obsessive-Compulsive Symptoms in Depression: A STAR*D Report

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Vortioxetine 10 mg and 20 mg in Adults With Major Depressive Disorder

A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 2 Doses of Vortioxetine in Adults With Major Depressive Disorder

Inflammation, Obesity, and Metabolic Syndrome in Depression: Analysis of the 2009-2010 National Health and Nutrition Examination Survey (NHANES)

Using Measurement-Based Care With Patient Involvement to Improve Outcomes in Depression

Influence of Sex and Menopausal Status on Response, Remission, and Recurrence in Patients With Recurrent Major Depressive Disorder Treated With Venlafaxine Extended Release or Fluoxetine: Analysis of Data From the PREVENT Study

A Randomized Controlled Trial of the Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults With Residual Symptoms of Major Depressive Disorder After Treatment With Escitalopram

Evaluating and Monitoring Treatment Response in Depression Using Measurement-Based Assessment and Rating Scales

Quantitative Electroencephalogram Biomarkers for Predicting Likelihood and Speed of Achieving Sustained Remission in Major Depression: A Report From the Biomarkers for Rapid Identification of Treatment Effectiveness in Major Depression (BRITE-MD) Trial

The Impact of Chronic Depression on Acute and Long-Term Outcomes in a Randomized Trial Comparing Selective Serotonin Reuptake Inhibitor Monotherapy Versus Each of 2 Different Antidepressant Medication Combinations

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles